Elong Power Holding Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of February 2026. Elong Power Holding Limited, a foreign private issuer based in Beijing, China, reported the completion of a public equity offering. The filing details an underwriting agreement entered into on February 2, 2026, with Maxim Group LLC, which closed on February 3, 2026.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, operating margins, or existing debt levels. The primary financial data relates to the capital raise:
- Gross Proceeds: Approximately $7.6 million.
- Offering Price: $3.16 per unit.
- Units Sold: 2,400,000 units (consisting of one Class A ordinary share and one warrant per unit).
- Underwriting Fee: 8.0% of gross proceeds.
- Expense Reimbursement: Up to $125,000.
- Over-Allotment: The underwriter partially exercised the option to purchase 242,270 additional Common Warrants.
Material Changes
The material change reported is the dilution of existing shareholders due to the issuance of new Class A ordinary shares and Common Warrants. The filing does not provide comparative financial data against a prior period to assess changes in operational performance.
Outlook, Risks, and Unusual Items
Use of Proceeds: The Company intends to use net proceeds for working capital and general corporate purposes.
Warrant Terms: The Common Warrants are exercisable immediately at $3.16 per share but include significant reset provisions. On the 4th and 8th trading days post-closing, the exercise price resets to 70% ($2.21) and 50% ($1.58) of the initial price, respectively, with the number of issuable shares increasing proportionately to maintain aggregate value. A zero exercise price option is also included, allowing holders to receive two shares for every one share issuable upon cash exercise without additional payment.
Risks: The filing notes standard legal disclaimers regarding the legality of offers in various jurisdictions but does not detail specific operational risks or contingencies beyond the terms of the offering.
Investor Verification Checklist
- Verify the exact net proceeds after deducting the 8% underwriting fee and the $125,000 expense reimbursement.
- Confirm the total number of shares outstanding post-offering to calculate the precise dilution impact.
- Review the full text of the Common Warrant agreement (Exhibit 4.1) to understand the mechanics of the price reset and zero exercise price options.
- Check subsequent filings for the actual deployment of the $7.6 million in gross proceeds.